3649 results for «2513»
3649 results
Tricuspid valve interventions - Case studies
19 Nov 2023 – From PCR London Valves 2023
Explore a diverse range of tricuspid valve interventions through various case studies such as the multimodality percutaneous treatment of severe tricuspid regurgitation, Triclip subacute single leaflet detachment, bicaval valve implantation and more.
TAVI in complex scenarios
19 Nov 2023 – From PCR London Valves 2023
What do we mean by "complex scenarios"? When zero-contrast TAVI implantation becomes a good alternative in kidney disease, when TAVI is implanted in a patient with mechanical mitral valve, or when TAVI is implanted in very large annulus with subannular aneurysm, for example!
Late-breaking trials on latest-generation aortic valves and dedicated transcatheter devices
20 Nov 2023 – From PCR London Valves 2023
Find out the outcomes of the main studies on the latest-generation valves and devices presented at PCR LV 2023 to better determine their benefits, performance and interest in the treatment of specific aortic pathologies: REACCESS-2 Study, ACURATE Neo2 PMCF post-market registry, OCEAN-TAVI registry, ShortCut Pivotal Study, and...
Mitral Late-Breaking Trials: CLASP IID, AltaValve transseptal programme, MitraSwiss in men and women, MiCLASP...
19 Nov 2023 – From PCR London Valves 2023
Discover the mitral late-breaking trials which were presented during PCR London Valves 2023:
- One-year outcomes of transcatheter mitral repair from the CLASP IID Registry
- AltaValve transseptal programme update
- Mitral TEER in men and women from MitraSwiss registry: is equality achieved?
- Combined impact of mitral valve gradients and mitral regurgitation reduction...
Tricuspid Late-Breaking Trials: TRISCEND at 2 years, TEER in primary tricuspid regurgitation, TriCLASP, bRIGHT...
19 Nov 2023 – From PCR London Valves 2023
Discover the tricuspid late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND study two-year outcomes: transfemoral TTVR
- Transcatheter edge-to-edge repair in patients with primary tricuspid regurgitation
- One-year outcomes of transcatheter tricuspid valve repair from the TriCLASP study
- TTVR with the LuX-Valve system: one-year outcomes of a multicentre experience
- Real-world...
Tricuspid TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...
19 Nov 2023 – From PCR London Valves 2023
Discover the top late-breaking trials which were presented during PCR London Valves 2023:
- TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
- Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
- Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
- Artificial intelligence derived risk...
Valve in valve - TAVI in SAV - Part 1
20 Nov 2023 – From PCR London Valves 2023
Explore innovative approaches in TAVI in SAV with this selection of cases: learn how to manage a degenerated surgical valve using a novel transcatheter heart valve, navigate low-contrast valve-in-valve scenarios in early bioprosthesis failure, witness the adaptability of TAVI valve-in-valve in a severely tortuous and horizontal...
TAVI outcomes - Part 1
19 Nov 2023 – From PCR London Valves 2023
Learn more about TAVI outcomes with this session: examine the impact of high-gradient and discordant low-gradient aortic stenosis, discover the potential of patient-specific computer simulation, explore the critical factor of time to TAVI and its implications in decompensated aortic stenosis cases, dive into the POPular TAVI...
Valve embolism and displacement
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn innovative strategies and management approaches for valve embolism and displacement: navigate the complexities of challenging severe aortic regurgitation, confront unexpected global myocardial ischemia during TAVI, explore the difficulties of a TAVI procedure in a surgical aortic valve with Evolut FX, and more!
Mitral TEER - Part 2
20 Nov 2023 – From PCR London Valves 2023
Discover compelling cases in TEER with this selection of cases: encounter the complexities of severe mitral regurgitation post-aortic root aneurysm repair, the urgency of percutaneous intervention in acute mitral regurgitation due to papillary muscle rupture, the challenges of acutely decompensated heart failure following complicated surgical AVR,...
TAVI - Patient selection
20 Nov 2023 – From PCR London Valves 2023
Gain essential insights into TAVI patient selection through these selected abstract submissions from PCR London Valves 2023: explore the benefits of guideline-directed therapy for severe aortic stenosis, unravel the significance of subthreshold aortic valve calcium scores in patients with cardiac amyloidosis and aortic stenosis, delve into...
Leaflet modification techniques
20 Nov 2023 – From PCR London Valves 2023
Discover cutting-edge leaflet modification approaches in transcatheter interventions with this selection of cases: explore the imaging aspects of the emerging ShortCut procedure for coronary protection in Valve-in-Valve TAVR, experience the effectiveness and simplicity of Balloon - Basilica for valve-in-valve interventions, learn about the adaptability of right...
Pulmonary valve interventions
20 Nov 2023 – From PCR London Valves 2023
Dive into pulmonary valve interventions with this selection of cases: explore the application of transcatheter pulmonary valve implantation in dysfunctional native right ventricular outflow tracts, witness the percutaneous treatment of iatrogenic pulmonary stenosis through transcatheter valve implantation, delve into percutaneous options for managing a large pulmonary...
TAVI - Durability and long-term outcomes
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn more about TAVI durability and long-term outcomes through a selection of abstracts: delve into a comprehensive five-year durability analysis of an intra-annular self-expandable transcatheter aortic bioprosthesis, navigate through the complexities of long-term outcomes associated with prosthesis-patient mismatch following valve-in-valve TAVI, explore...
Key questions in mitral valve intervention - What do I need to know about imaging?
19 Nov 2023 – From PCR London Valves 2023
Explore the crucial aspects of imaging in mitral valve intervention with a focus on the entire treatment pathway, from patient selection to post-procedural follow-up. Gain insights into optimizing patient selection for mitral valve edge-to-edge repair and replacement, and learn key views essential for optimal imaging and...
TAVI in bicuspid anatomy - Part 2
20 Nov 2023 – From PCR London Valves 2023
Consult this session to learn more about TAVI challenges in diverse bicuspid anatomical scenarios: witness the difficulties of TAVI in a bicuspid aortic valve with unrepaired aortic coarctation, delve into the nuances of treating a type 0 bicuspid aortic valve with anomalous coronary arteries, gain insights...
Key questions in tricuspid valve intervention - How do I define treatment options according to individual patient anatomy?
19 Nov 2023 – From PCR London Valves 2023
Explore this tricuspid valve-focused session featuring analysis of four clinical cases: Ebstein anomaly, severe and torrential tricuspid regurgitations, and anterior flail-related torrential regurgitation. Gain insights into optimal treatment selection for each scenario, leveraging pre-procedural imaging for informed decision-making.
Tricuspid valve interventions in patients with pacemakers and defibrillators
20 Nov 2023 – From PCR London Valves 2023
Mitral valve intervention in complex scenarios - Transcatheter mitral valve replacement - who are the eligible patients, and what are the available options?
21 Nov 2023 – From PCR London Valves 2023
This PCR London Valves 2023 session about mitral valve interventions seeks to address three key questions: identifying the ideal patient for Transcatheter Mitral Valve Implantation (TMVI), exploring treatment alternatives for ineligible patients, and discussing the prediction and management of left ventricular outflow tract obstruction. Watch video...
